Akbar A, Yiangou Y, Facer P, Walters JR, Anand P, Ghosh S Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain. Gut. 2008 Jul;57(7):923-9. doi: 10.1136/gut.2007.138982. Epub 2008 Feb 5.
Bienenstock J, Collins S 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: psycho-neuroimmunology and the intestinal microbiota: clinical observations and basic mechanisms. Clin Exp Immunol. 2010 Apr;160(1):85-91. doi: 10.1111/j.1365-2249.2010.04124.x.
Böhmelt AH, Nater UM, Franke S, Hellhammer DH, Ehlert U Basal and stimulated hypothalamic-pituitary-adrenal axis activity in patients with functional gastrointestinal disorders and healthy controls. Psychosom Med. 2005 Mar-Apr;67(2):288-94.
Carpenter S That gut feeling. Monitor on Psychol 2012; 43:51-55
Chrousos GP Stress, chronic inflammation, and emotional and physical well-being: concurrent effects and chronic sequelae. J Allergy Clin Immunol. 2000 Nov;106(5 Suppl):S275-91. Review.
Cryan JF, O'Mahony SM The microbiome-gut-brain axis: from bowel to behavior. Neurogastroenterol Motil. 2011 Mar;23(3):187-92. doi: 10.1111/j.1365-2982.2010.01664.x.
Edgar RC Search and clustering orders of magnitude faster than BLAST. Bioinformatics. 2010 Oct 1;26(19):2460-1. doi: 10.1093/bioinformatics/btq461. Epub 2010 Aug 12.
Friesen CA, Andre L, Garola R, Hodge C, Roberts C Activated duodenal mucosal eosinophils in children with dyspepsia: a pilot transmission electron microscopic study. J Pediatr Gastroenterol Nutr. 2002 Sep;35(3):329-33.
Fukudo S, Nomura T, Hongo M Impact of corticotropin-releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and patients with irritable bowel syndrome. Gut. 1998 Jun;42(6):845-9.
Grenham S, Clarke G, Cryan JF, Dinan TG Brain-gut-microbe communication in health and disease. Front Physiol. 2011 Dec 7;2:94. doi: 10.3389/fphys.2011.00094. eCollection 2011.
Hall W, Buckley M, Crotty P, O'Morain CA Gastric mucosal mast cells are increased in Helicobacter pylori-negative functional dyspepsia. Clin Gastroenterol Hepatol. 2003 Sep;1(5):363-9.
He SH Key role of mast cells and their major secretory products in inflammatory bowel disease. World J Gastroenterol. 2004 Feb 1;10(3):309-18. Review.
Konturek PC, Brzozowski T, Konturek SJ Stress and the gut: pathophysiology, clinical consequences, diagnostic approach and treatment options. J Physiol Pharmacol. 2011 Dec;62(6):591-9. Review.
La JH, Sung TS, Kim HJ, Kim TW, Kang TM, Yang IS Peripheral corticotropin releasing hormone mediates post-inflammatory visceral hypersensitivity in rats. World J Gastroenterol. 2008 Feb 7;14(5):731-6.
Leung L, Cahill CM TNF-alpha and neuropathic pain--a review. J Neuroinflammation. 2010 Apr 16;7:27. doi: 10.1186/1742-2094-7-27. Review.
Li Y, Ji YJ, Jiang H, Liu DX, Zhang Q, Fan SJ, Pan F Effects of unpredictable chronic stress on behavior and brain-derived neurotrophic factor expression in CA3 subfield and dentate gyrus of the hippocampus in different aged rats. Chin Med J (Engl). 2009 Jul 5;122(13):1564-9.
Lozupone C, Knight R UniFrac: a new phylogenetic method for comparing microbial communities. Appl Environ Microbiol. 2005 Dec;71(12):8228-35.
Lyte M, Li W, Opitz N, Gaykema RP, Goehler LE Induction of anxiety-like behavior in mice during the initial stages of infection with the agent of murine colonic hyperplasia Citrobacter rodentium. Physiol Behav. 2006 Oct 30;89(3):350-7. Epub 2006 Aug 2.
Matsumoto K, Lo MW, Hosoya T, Tashima K, Takayama H, Murayama T, Horie S Experimental colitis alters expression of 5-HT receptors and transient receptor potential vanilloid 1 leading to visceral hypersensitivity in mice. Lab Invest. 2012 May;92(5):769-82. doi: 10.1038/labinvest.2012.14. Epub 2012 Feb 13.
Neufeld KM, Kang N, Bienenstock J, Foster JA Reduced anxiety-like behavior and central neurochemical change in germ-free mice. Neurogastroenterol Motil. 2011 Mar;23(3):255-64, e119. doi: 10.1111/j.1365-2982.2010.01620.x. Epub 2010 Nov 5.
Price MN, Dehal PS, Arkin AP FastTree: computing large minimum evolution trees with profiles instead of a distance matrix. Mol Biol Evol. 2009 Jul;26(7):1641-50. doi: 10.1093/molbev/msp077. Epub 2009 Apr 17.
Schurman JV, Singh M, Singh V, Neilan N, Friesen CA Symptoms and subtypes in pediatric functional dyspepsia: relation to mucosal inflammation and psychological functioning. J Pediatr Gastroenterol Nutr. 2010 Sep;51(3):298-303. doi: 10.1097/MPG.0b013e3181d1363c.
Shi SS, Shao SH, Yuan BP, Pan F, Li ZL Acute stress and chronic stress change brain-derived neurotrophic factor (BDNF) and tyrosine kinase-coupled receptor (TrkB) expression in both young and aged rat hippocampus. Yonsei Med J. 2010 Sep;51(5):661-71. doi: 10.3349/ymj.2010.51.5.661.
White FA, Feldman P, Miller RJ Chemokine signaling and the management of neuropathic pain. Mol Interv. 2009 Aug;9(4):188-95. doi: 10.1124/mi.9.4.7. Review.
Wood JD Enteric neuroimmunophysiology and pathophysiology. Gastroenterology. 2004 Aug;127(2):635-57. Review.
Yang CQ, Wei YY, Zhong CJ, Duan LP Essential role of mast cells in the visceral hyperalgesia induced by T. spiralis infection and stress in rats. Mediators Inflamm. 2012;2012:294070. doi: 10.1155/2012/294070. Epub 2012 Mar 7.
Yang J, Yu Y, Yu H, Zuo X, Liu C, Gao L, Chen ZY, Li Y The role of brain-derived neurotrophic factor in experimental inflammation of mouse gut. Eur J Pain. 2010 Jul;14(6):574-9. doi: 10.1016/j.ejpain.2009.10.007. Epub 2009 Nov 20.
Youssef NN, Murphy TG, Langseder AL, Rosh JR Quality of life for children with functional abdominal pain: a comparison study of patients' and parents' perceptions. Pediatrics. 2006 Jan;117(1):54-9.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.